TQB3201 tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TQB3201 tablets, covering 2025-09-15 to 2025-09-15. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Tolerance of TQB3201 Tablets [Phase 1, Phase 2]